Joan Levy

7.0k total citations
58 papers, 3.6k citations indexed

About

Joan Levy is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Joan Levy has authored 58 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 18 papers in Oncology and 12 papers in Hematology. Recurrent topics in Joan Levy's work include Protein Degradation and Inhibitors (13 papers), Multiple Myeloma Research and Treatments (12 papers) and Bone Metabolism and Diseases (10 papers). Joan Levy is often cited by papers focused on Protein Degradation and Inhibitors (13 papers), Multiple Myeloma Research and Treatments (12 papers) and Bone Metabolism and Diseases (10 papers). Joan Levy collaborates with scholars based in United States, Canada and Poland. Joan Levy's co-authors include Roland Baron, Lynn Neff, Gilad Barnea, William C. Horne, Sakae Tanaka, Hidesaburô Hanafusa, Hideo Iba, Olli Silvennoinen, Joan S. Brugge and Peter Canoll and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Joan Levy

56 papers receiving 3.5k citations

Peers

Countries citing papers authored by Joan Levy

Since Specialization

Citations

This map shows the geographic impact of Joan Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Levy more than expected).

Fields of papers citing papers by Joan Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Levy. The network helps show where Joan Levy may publish in the future.

Co-authorship network of co-authors of Joan Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Levy. A scholar is included among the top collaborators of Joan Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Levy. Joan Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repurposing a Combination of Palbociclib and Afatinib Halts Chordoma Growth in a Mouse Model 2025 ·Renuka Raman, Joan Levy, Daniel M. Freed, Sean Ekins	0
2	US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma 2024 ·Critical Reviews in Oncology/Hematology ·Rachel A. Fischer, I. Ryan, (unknown), (unknown), (unknown), Joan Levy, Jason J. Luke, Andrew Poklepovic, Marc Hurlbert	1
3	Mapping the landscape of genetic dependencies in chordoma 2023 ·Nature Communications ·Tanaz Sharifnia, Mathias J. Wawer, Amy Goodale, Yenarae Lee, Mariya Kazachkova, Joshua M. Dempster, Sandrine Muller, Joan Levy, Daniel M. Freed, Josh Sommer, Jérémie Kalfon, Francisca Vázquez, William C. Hahn, David E. Root, Paul A. Clemons, Stuart L. Schreiber	17
4	Abstract 6195: Assessing replication stress as an actionable therapeutic opportunity in chordoma 2023 ·Cancer Research ·(unknown), Lee Dolat, Wendy Leung, Joan Levy, Lee Zou, Daniel M. Freed, Gregory M. Coté	0
5	Abstract 4865: Mechanisms of EGFR inhibitor sensitivity and resistance in chordoma 2023 ·Cancer Research ·(unknown), Lee Dolat, Joan Levy, Josh Sommer, Daniel M. Freed	1
6	Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms 2022 ·Frontiers in Oncology ·Christopher J. Walker, Hua Chang, (unknown), Trinayan Kashyap, Sharon Shacham, Josh Sommer, Michael J. Wick, Joan Levy, Yosef Landesman	4
7	Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity 2021 ·Cell Reports Medicine ·(unknown), Alessandra Dall’Agnese, (unknown), (unknown), Julien Dubrulle, Hannah L. Johnson, Fabio Stossi, Patricia C. Cogswell, Josh Sommer, Joan Levy, Tanaz Sharifnia, Mathias J. Wawer, Behnam Nabet, Nathanael S. Gray, Paul A. Clemons, Stuart L. Schreiber, Paul Workman, Richard A. Young, Charles Y. Lin	20
8	A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5 2018 ·Blood Cancer Journal ·Brian S. White, Irena Lanc, Julie O’Neal, (unknown), Robert S. Fulton, Heather K. Schmidt, Catrina C. Fronick, Edward A. Belter, Mark A. Fiala, Justin King, Greg Ahmann, Mary DeRome, Elaine R. Mardis, Ravi Vij, John F. DiPersio, Joan Levy, Daniel Auclair, Michael H. Tomasson	35
9	Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma 2013 ·Haematologica ·Scott Van Wier, Esteban Braggio, Angela Baker, Gregory Ahmann, Joan Levy, John D. Carpten, Rafaël Fonseca	48
10	Analysis of transcription and protein expression changes in the 786-O human renal cell carcinoma tumor xenograft model in response to treatment with the multi-kinase inhibitor sorafenib (BAY 43-9006) 2006 ·Cancer Research ·Joan Levy, (unknown), Déborah Braun, Mary DeRome, (unknown), Hong Shi, Daniel C. Weaver, Yong S. Chang, Elizabeth Bortolon, Arris J. Henderson, (unknown), Amy Burd, James J. Elting, Mark Lynch, Sanjeeva Reddy, Scott M. Wilhelm	25
11	Molecular complexes that contain both c-Cbl and c-Src associate with Golgi membranes 2002 ·European Journal of Cell Biology ·Frédéric Bard, (unknown), Joan Levy, William C. Horne, Roland Baron	38
12	Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts 1997 ·Molecular Reproduction and Development ·Karl Insogna, Sakae Tanaka, Lynn Neff, William C. Horne, Joan Levy, Roland Baron	23
13	Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. 1996 ·Endocrinology ·Joan Levy, Christian Schindler, Regina Raz, David T. Levy, Roland Baron, Mark C. Horowitz	53
14	c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption 1996 ·Nature ·Sakae Tanaka, Michael Amling, Lynn Neff, Anusch Peyman, Eugen Uhlmann, Joan Levy, Roland Baron	253
15	Speech and Swallowing Rehabilitation Following Devastating Caustic Ingestion: Techniques and Indicators for Success 1996 ·The Laryngoscope ·Mark J. Shikowitz, Joan Levy, (unknown), L. Michael Graver, Rubem Pochaczevsky	29
16	Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. 1994 ·Journal of Biological Chemistry ·Gilad Barnea, Martin Grumet, (unknown), Olli Silvennoinen, Joan Levy, John Sap, Joseph Schlessinger	162
17	Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. 1993 ·Molecular and Cellular Biology ·Gilad Barnea, Olli Silvennoinen, Boaz Shaanan, Annemarie Honegger, Peter Canoll, Peter D’Eustachio, (unknown), Joan Levy, (unknown), Kay Huebner	89
18	Speech patterns following partial glossectomy for small tumors of the tongue 1991 ·Head & Neck ·Keith S. Heller, Joan Levy, James J. Sciubba	23
19	Amino Acid Substitutions Sufficient To Convert the Nontransforming p60 ^{c- src} Protein to a Transforming Protein 1986 ·Molecular and Cellular Biology ·Jun‐ya Kato, Tatsuo Takeya, Carla Grandori, Hideo Iba, Joan Levy, Hidesaburô Hanafusa	17
20	A chemically cleavable biotinylated nucleotide: usefulness in the recovery of protein-DNA complexes from avidin affinity columns. 1985 ·Proceedings of the National Academy of Sciences ·(unknown), Joan Levy, Tim Herman	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact